IL320743A - Method of treating prostate cancer - Google Patents
Method of treating prostate cancerInfo
- Publication number
- IL320743A IL320743A IL320743A IL32074325A IL320743A IL 320743 A IL320743 A IL 320743A IL 320743 A IL320743 A IL 320743A IL 32074325 A IL32074325 A IL 32074325A IL 320743 A IL320743 A IL 320743A
- Authority
- IL
- Israel
- Prior art keywords
- prostate cancer
- treating prostate
- treating
- cancer
- prostate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263386040P | 2022-12-05 | 2022-12-05 | |
| US18/448,609 US20240197926A1 (en) | 2022-12-05 | 2023-08-11 | Method of treating prostate cancer |
| US202363592377P | 2023-10-23 | 2023-10-23 | |
| PCT/IB2023/062204 WO2024121722A1 (en) | 2022-12-05 | 2023-12-04 | Method of treating prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320743A true IL320743A (en) | 2025-07-01 |
Family
ID=89222088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320743A IL320743A (en) | 2022-12-05 | 2023-12-04 | Method of treating prostate cancer |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4630063A1 (en) |
| JP (1) | JP2025541733A (en) |
| KR (1) | KR20250116127A (en) |
| CN (1) | CN120303009A (en) |
| AU (1) | AU2023389426A1 (en) |
| IL (1) | IL320743A (en) |
| MX (1) | MX2025006427A (en) |
| TW (1) | TW202440171A (en) |
| WO (1) | WO2024121722A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024317528A1 (en) | 2023-07-31 | 2026-03-05 | Curium Us Llc | [177 lu] lutetium-psma it composition and dosimetry, kit, method of making, and method of using thereof |
| JPWO2025058000A1 (en) | 2023-09-13 | 2025-03-20 | ||
| CN121445909A (en) * | 2026-01-04 | 2026-02-03 | 润方(北京)生物医药研究院有限公司 | Application of hemoglobin oxygen carrier combined with radionuclide drug in treating prostate cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002013610A1 (en) | 2000-08-17 | 2002-02-21 | Mirus Corporation | Nucleic acid expression from linear nucleic acids |
| US11129912B1 (en) | 2020-07-13 | 2021-09-28 | POINT Biopharma Inc. | Radiopharmaceutical and methods |
| JP2023539990A (en) | 2020-07-13 | 2023-09-21 | ポイント バイオファーマ インコーポレイテッド | Radiopharmaceuticals and methods |
-
2023
- 2023-12-04 EP EP23822457.0A patent/EP4630063A1/en active Pending
- 2023-12-04 IL IL320743A patent/IL320743A/en unknown
- 2023-12-04 KR KR1020257022105A patent/KR20250116127A/en active Pending
- 2023-12-04 AU AU2023389426A patent/AU2023389426A1/en active Pending
- 2023-12-04 WO PCT/IB2023/062204 patent/WO2024121722A1/en not_active Ceased
- 2023-12-04 CN CN202380083172.7A patent/CN120303009A/en active Pending
- 2023-12-04 TW TW112147119A patent/TW202440171A/en unknown
- 2023-12-04 JP JP2025531618A patent/JP2025541733A/en active Pending
-
2025
- 2025-06-02 MX MX2025006427A patent/MX2025006427A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4630063A1 (en) | 2025-10-15 |
| TW202440171A (en) | 2024-10-16 |
| CN120303009A (en) | 2025-07-11 |
| KR20250116127A (en) | 2025-07-31 |
| JP2025541733A (en) | 2025-12-23 |
| WO2024121722A1 (en) | 2024-06-13 |
| MX2025006427A (en) | 2025-09-02 |
| AU2023389426A1 (en) | 2025-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL320332A (en) | Methods for treating cancer | |
| EP4111202A4 (en) | Methods of treating cancer | |
| IL320962A (en) | Methods of treating advanced solid tumors | |
| IL289811A (en) | Method of treating cancer | |
| IL325326A (en) | Method of treating cancer with indoline inhibitors of kif18a | |
| IL326327A (en) | Prostate cancer treatment | |
| IL325454A (en) | Method of treating prostate cancer | |
| IL314798A (en) | Methods of treating prostate cancer | |
| IL312155A (en) | Method of cancer treatment | |
| IL272390A (en) | Methods of treating cancer | |
| CA3274501A1 (en) | Method of treating prostate cancer | |
| IL315569A (en) | Methods of treating cancer | |
| HK40122526A (en) | Methods of treating prostate cancer | |
| HK40087831A (en) | Methods of treating prostate cancer | |
| IL312332A (en) | Methods of treating cancer | |
| IL320448A (en) | Methods of treating cancer with sotorasib | |
| CA3297160A1 (en) | Method for treating prostate cancer | |
| CA3265149A1 (en) | Methods of treating prostate cancer using exicorilant and enzalutamide | |
| GB202412414D0 (en) | Methods for treating cancer | |
| IL326216A (en) | Combination therapy for prostate cancer | |
| GB202013074D0 (en) | Method of treatment for cancer | |
| CA3310617A1 (en) | Methods of treating cancer | |
| AU2024377510A1 (en) | Methods of treating cancer | |
| CA3293232A1 (en) | Methods of treating cancer | |
| GB202006474D0 (en) | Method of treatment of cancer or tumour |